Promoting economic value in public health

European Journal of Public Health

Volumn 18, Issue 3, 2008, Pages 216-

  Leidl, Reiner ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DECISION MAKING; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH PROMOTION; INTERVENTION STUDY; LIFESTYLE; OBESITY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REIMBURSEMENT; RISK ASSESSMENT; RISK FACTOR; SAFETY; SMOKING; SOCIOECONOMICS;

COST-BENEFIT ANALYSIS; EUROPEAN UNION; HEALTH BEHAVIOR; HEALTH CARE COSTS; HUMANS; PREVENTIVE MEDICINE; PUBLIC HEALTH;

EID: 44649107068     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckn035     Document Type: Editorial

References (6)

1. Hutton J, McGrath C, Frybourg JM, et al. Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems). Int J Technol Assess Health Care 2006;22:10-8.
2. Holland WW. Health technology assessment and public health: a commentary. Int J Technol Assess Health Care 2004;20:77-80.
3. Banta HD, de Wit A. Public health services and cost-effectiveness analysis. Annu Rev Public Health 2008;29:383-97.
4. Chalkidou K, Culyer A, Naidoo B, Littlejohns P. Cost-effective public health guidance: asking questions from the decision-maker's viewpoint. Health Econ 2008;17:441-8.
5. Grosse SD, Teutsch SM, Haddix AC. Lessons from cost-effectiveness research for United States public health policy. Annu Rev Public Health 2007;28:365-91.
6. Humphries SE, Cooper JA, Talmud PJ, Miller GJ. Candidate gene genotypes, along with conventional risk factor assessment, improve estimation of coronary heart disease risk in healthy UK men. Clin Chem 2007;53:8-16.